Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer.
Yanping SuMeirong HuoLin HuaYuan ZhangJiawen YiShu ZhangJie LiYuhui ZhangPublished in: Cancer management and research (2021)
Patients with an EGFR mutation/ALK rearrangement had a significantly decreased risk of early mortality in the era of targeted therapy; however, VTE occurrence remained an important predictor for early mortality in metastatic NSCLC patients, especially in patients with EGFR/ALK wild-type genes.
Keyphrases
- small cell lung cancer
- newly diagnosed
- venous thromboembolism
- cardiovascular events
- advanced non small cell lung cancer
- epidermal growth factor receptor
- squamous cell carcinoma
- end stage renal disease
- wild type
- risk factors
- tyrosine kinase
- ejection fraction
- chronic kidney disease
- risk assessment
- prognostic factors
- coronary artery disease
- type diabetes
- cardiovascular disease
- peritoneal dialysis
- genome wide
- gene expression
- dna methylation
- transcription factor
- bioinformatics analysis
- genome wide analysis